The global Losartan Market, valued at US$ 1.5 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2034, reaching US$ 2.3 billion by 2034. Losartan, an angiotensin II receptor blocker (ARB), is widely used to treat hypertension, heart failure, and diabetic nephropathy. The market encompasses branded and generic formulations, available in t... https://www.transparencymarketresearch.com/losartan-market.html